These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34427100)

  • 1. SLC7A11 negatively associates with mismatch repair gene expression and endows glioblastoma cells sensitive to radiation under low glucose conditions.
    Hu N; Hu WH; Zhou SL; Yang Z; Liang WL; Yang RY; Li MH; Jing Z; Li ZA; Fu XD; Wang XJ
    Neoplasma; 2021 Nov; 68(6):1147-1156. PubMed ID: 34427100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine/glutamate transporter xCT (SLC7A11).
    Yamaguchi I; Yoshimura SH; Katoh H
    J Biol Chem; 2020 May; 295(20):6936-6945. PubMed ID: 32265299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor promotes glioblastoma cell death under glucose deprivation via upregulation of xCT (SLC7A11).
    Yamamoto M; Teramoto K; Katoh H
    Cell Signal; 2021 Feb; 78():109874. PubMed ID: 33285240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
    Koppula P; Zhang Y; Shi J; Li W; Gan B
    J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPKα1-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma.
    Wang Z; Wang Y; Shen N; Liu Y; Xu X; Zhu R; Jiang H; Wu X; Wei Y; Tang J
    Cancer Lett; 2024 Mar; 584():216619. PubMed ID: 38211651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merlin/NF2 regulates SLC7A11/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells.
    Yamaguchi I; Katoh H
    J Biochem; 2024 Mar; 175(3):313-322. PubMed ID: 38102738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P; Zhuang L; Gan B
    Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.
    Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS
    Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.
    Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Cassady K; Aboody KS
    Mol Cancer Res; 2016 Dec; 14(12):1229-1242. PubMed ID: 27658422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress-induced inhibition of nonsense-mediated RNA decay regulates intracellular cystine transport and intracellular glutathione through regulation of the cystine/glutamate exchanger SLC7A11.
    Martin L; Gardner LB
    Oncogene; 2015 Aug; 34(32):4211-8. PubMed ID: 25399695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer.
    Koppula P; Zhang Y; Zhuang L; Gan B
    Cancer Commun (Lond); 2018 Apr; 38(1):12. PubMed ID: 29764521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting SIRT3 sensitizes glioblastoma to ferroptosis by promoting mitophagy and inhibiting SLC7A11.
    Li X; Zhang W; Xing Z; Hu S; Zhang G; Wang T; Wang T; Fan Q; Chen G; Cheng J; Jiang X; Cai R
    Cell Death Dis; 2024 Feb; 15(2):168. PubMed ID: 38395990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer.
    Liu X; Olszewski K; Zhang Y; Lim EW; Shi J; Zhang X; Zhang J; Lee H; Koppula P; Lei G; Zhuang L; You MJ; Fang B; Li W; Metallo CM; Poyurovsky MV; Gan B
    Nat Cell Biol; 2020 Apr; 22(4):476-486. PubMed ID: 32231310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance.
    Huang Y; Dai Z; Barbacioru C; Sadée W
    Cancer Res; 2005 Aug; 65(16):7446-54. PubMed ID: 16103098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity.
    Tan SLW; Tan HM; Israeli E; Fatihah I; Ramachandran V; Ali SB; Goh SJA; Wee J; Tan AQL; Tam WL; Han W
    Biochem J; 2023 Dec; 480(24):2045-2058. PubMed ID: 38078799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
    Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP
    J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROS Mediate xCT-Dependent Cell Death in Human Breast Cancer Cells under Glucose Deprivation.
    Chen MC; Hsu LL; Wang SF; Hsu CY; Lee HC; Tseng LM
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells.
    Yan Y; Teng H; Hang Q; Kondiparthi L; Lei G; Horbath A; Liu X; Mao C; Wu S; Zhuang L; James You M; Poyurovsky MV; Ma L; Olszewski K; Gan B
    Nat Commun; 2023 Jun; 14(1):3673. PubMed ID: 37339981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. xCT (SLC7A11) expression confers intrinsic resistance to physical plasma treatment in tumor cells.
    Bekeschus S; Eisenmann S; Sagwal SK; Bodnar Y; Moritz J; Poschkamp B; Stoffels I; Emmert S; Madesh M; Weltmann KD; von Woedtke T; Gandhirajan RK
    Redox Biol; 2020 Feb; 30():101423. PubMed ID: 31931281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation.
    Liu X; Zhang Y; Zhuang L; Olszewski K; Gan B
    Genes Dis; 2021 Nov; 8(6):731-745. PubMed ID: 34522704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.